TEQ — Terranueva Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Terranueva, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2013 September 30th | 2014 September 30th | 2015 September 30th | 2016 September 30th | 2017 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.566 | 2.27 | 0.387 | 0.371 | 0.9 |
Operating Profit | -0.566 | -2.27 | -0.387 | -0.371 | -0.9 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.524 | -2.26 | -0.364 | -0.353 | -0.886 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.498 | -2.2 | -0.341 | -0.353 | -0.85 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.498 | -2.2 | -0.341 | -0.353 | -0.85 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.498 | -2.2 | -0.341 | -0.353 | -0.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.019 | -0.006 | -0.006 | -0.009 |
Dividends per Share |